Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

Trump’s planned pharmaceutical tariffs would raise costs by $51bn annually, report finds - Prices of medication and other ...

The United States has a $115.5 billion trade deficit in pharmaceutical products, which the Trump administration has suggested ...

As President Trump prepares to announce pharmaceutical tariffs, he has one country, in particular, in his sights: Ireland.

The pharmaceutical industry's next billion-dollar blockbuster won't come from a lab alone—it will come from listening to ...

The Trump administration’s threat of pharmaceutical tariffs could risk significant political backlash, as the drug industry ...

The FDA will remove industry representatives from advisory committees and replace them with patients and caregivers ...

While the drug industry was spared that day, he clearly stated that it was next in line. “The pharmaceutical companies are ...

The European Commission has no plans to withdraw or revise its proposed overhaul of EU pharmaceutical rules, despite mounting ...

An investigation into the national security implications of pharma imports has been underway for two weeks, the Trump ...

Pharmaceutical Technology® Group spoke with Erik Wiklund, CEO of Circio, about the future of M&A in the bio/pharmaceutical industry and the struggle small biotech companies face raising funds.

Learn how a 25% Pharma tariff could raise U.S. drug costs by nearly $51 billion annually and impact prices significantly.